|
Post by robsacher on Jan 13, 2016 22:11:32 GMT -5
I feel a heck of a lot better today than I did yesterday ! I was happy to hear that the code of Silence has been lifted & that he wants to hold a separate CC in the near future for Shareholders . From some of the things he said today it seems like he may have received some of his ideas from this board such as persuing SM & opening Diabetes clinics ,) Over all I was happy with the call & it was refreshing to hear Matt today vs the CC after the Sanofi bomb was dropped . He was enthusiastic & I also think Ray did a fine job Though I haven't convinced myself to buy more just yet I nolonger feel like I want to avoid running into the people that I told about this stock ,) Lynn I feel the same way, Lynn. I have been feeling this positivity growing inside myself for a couple of days now. I have always had confidence in Matt. His quote about making it his mission to fulfill Al Mann's vision goes directly to the heart of the matter. That's why we too are still here, I think. We are all interconnected and I very much agree with you that Matt is open to ideas that are expressed here. Ray was also very good. He has a gutty demeanor, straight shooter. It was a good day, a very good day...
|
|
|
Post by dreamboatcruise on Jan 13, 2016 22:26:11 GMT -5
EXCITED to see potential TS uses in MRSA and fungal infections such as aspergillosis as in theory should be more effective given alveolar absorption in contrast to venous access. Also, in the setting of acute pain, TS Fentanyl could be a very handy tool to have in the ER for trauma patients not to mention acute pain patients on the battlefield or any patient for that matter who do not have IV access. Given many of these have potential to be used by our military, and given Al Manns history of working with the military and NASA, I do not think it would be a surprise to see Fed grant money to further research and develop some of these TS candidates. Al has been out of DoD world for too long for contacts to be relevant. A lot of those organizations have high turn over. DARPA has a policy that their program managers are only there for 4 years. The overhead of dealing with DoD is high as well.
|
|
|
Post by mnholdem on Jan 13, 2016 22:35:28 GMT -5
Does anybody remember Matt saying MannKind will be contracting 3rd party payers reimbursement negotiators? I thought he stated something to that effect immediatelyafter stating that there may be some contracts needed in the short term for sales specialists.
---
Also, I think one of the best shoutbox comments was (paraphrased): Tomorrow Adam F will be writing that MannKind needs to sell off property for cash. Sorry that I don't remember the board member who wrote it.
|
|
|
Post by dreamboatcruise on Jan 13, 2016 22:39:17 GMT -5
My take: Cash issues not resolved in the least. No partner except a promise they are close to having one for a Phase 1 product. Matt - an accountant - is going to run the company. Al - a humanitarian with no serious interest in wealth preservation - is still chairman. Buyout offer, if one exists ( doubtful) almost certainly not going to be accepted by BOD so long as Al is alive. Starting from square one with DTC, trials, and coverage negotiations with $8M per month cash burn under best case scenario but expenses likely to rise even before end Q1. Altogether, I want to crawl inder the house and die. Horrible situation and no hope for serious investor return in the short or long term. Only good for day traders now. Signing off... Ok... I think I may be ready to crawl out from under the house thanks to a bit of optimism from today's call... you can take my spot. You'll know which spot because it is littered with tear stained brokerage statements. True that cash issue isn't resolved, but seems like MNKD is now in full bore let's act like an innovative start-up mode... and I can fully appreciate that. No doubt we'll have some dilution... that was all but said.
|
|
|
Post by stevil on Jan 13, 2016 22:42:16 GMT -5
wow.. thanks so much for the recap .. it all sounds so positive and finally MNKD is telling us something .. I especially like the part where they say "Afrezza and MNKD are here to stay"... what a relief coming from the mouth of the new CEO .. now I think I may consider doubling what I own.... and maybe in a year or so my dad can be back on Afrezza ...
Please tell me you aren't serious? doubling your position only because Matt said positive things? Please be wiser than this ha. Our situation has not improved since yesterday. This is still a long shot. It just looks like MNKD employees are motivated and hungry to take it head on. Unless your position is relatively small, please don't double it yet. Wait until we at least get on stable ground. There are better places for your money until that time.
|
|
|
Post by esstan2001 on Jan 13, 2016 22:53:46 GMT -5
EXCITED to see potential TS uses in MRSA and fungal infections such as aspergillosis as in theory should be more effective given alveolar absorption in contrast to venous access. Also, in the setting of acute pain, TS Fentanyl could be a very handy tool to have in the ER for trauma patients not to mention acute pain patients on the battlefield or any patient for that matter who do not have IV access. Given many of these have potential to be used by our military, and given Al Manns history of working with the military and NASA, I do not think it would be a surprise to see Fed grant money to further research and develop some of these TS candidates. Al has been out of DoD world for too long for contacts to be relevant. A lot of those organizations have high turn over. DARPA has a policy that their program managers are only there for 4 years. The overhead of dealing with DoD is high as well. Isn't Kent Kresa (on our BoD) Chairman (or former) of Northrop Grumman or something like that? Take it for what it's worth- even Al is likely still connected, albeit weakly.
|
|
|
Post by sweedee79 on Jan 14, 2016 0:23:55 GMT -5
wow.. thanks so much for the recap .. it all sounds so positive and finally MNKD is telling us something .. I especially like the part where they say "Afrezza and MNKD are here to stay"... what a relief coming from the mouth of the new CEO .. now I think I may consider doubling what I own.... and maybe in a year or so my dad can be back on Afrezza ...
Please tell me you aren't serious? doubling your position only because Matt said positive things? Please be wiser than this ha. Our situation has not improved since yesterday. This is still a long shot. It just looks like MNKD employees are motivated and hungry to take it head on. Unless your position is relatively small, please don't double it yet. Wait until we at least get on stable ground. There are better places for your money until that time. thanks for your concern .. but I was already considering this before the conference .. so no I'm not jumping in just because of today..
|
|
|
Post by themarlin on Jan 14, 2016 1:02:21 GMT -5
My take: Cash issues not resolved in the least. No partner except a promise they are close to having one for a Phase 1 product. Matt - an accountant - is going to run the company. Al - a humanitarian with no serious interest in wealth preservation - is still chairman. Buyout offer, if one exists ( doubtful) almost certainly not going to be accepted by BOD so long as Al is alive. Starting from square one with DTC, trials, and coverage negotiations with $8M per month cash burn under best case scenario but expenses likely to rise even before end Q1. Altogether, I want to crawl inder the house and die. Horrible situation and no hope for serious investor return in the short or long term. Only good for day traders now. Signing off... I appreciate your perspective. Things might have taken a turn in the last few days and they're excited to be unshackled. But it's really too early to tell if they'll make it, and they're near bottom of survivability right now. They must execute cost-cutting measures and increase revenue very soon, and those in decision making positions aren't normally what you'd hope for or find creating success in business. I do take note that Matt is not just an accountant but has also raised $100's of millions during his tenure at Mannkind.
|
|
|
Post by babaoriley on Jan 14, 2016 1:10:09 GMT -5
Does anybody remember Matt saying MannKind will be contracting 3rd party payers reimbursement negotiators? I thought he stated something to that effect immediatelyafter stating that there may be some contracts needed in the short term for sales specialists.
---
Also, I think one of the best shoutbox comments was (paraphrased): Tomorrow Adam F will be writing that MannKind needs to sell off property for cash. Sorry that I don't remember the board member who wrote it. I wish he had to write that MNKD bought $100 of power ball tickets in desperation and hit the jackpot! Heard of at least one winner, that being from Chino Hills, about 30 miles east of LA - I wonder if the winner would be interested in supporting MNKD with a little financing!
|
|
|
Post by nylefty on Jan 14, 2016 1:15:49 GMT -5
Please tell me you aren't serious? doubling your position only because Matt said positive things? Please be wiser than this ha. Our situation has not improved since yesterday. This is still a long shot. It just looks like MNKD employees are motivated and hungry to take it head on. Unless your position is relatively small, please don't double it yet. Wait until we at least get on stable ground. There are better places for your money until that time. thanks for your concern .. but I was already considering this before the conference .. so no I'm not jumping in just because of today..
I admire your restraint. I would have reacted a little more strongly to his "concern."
|
|
|
Post by seanismorris on Jan 14, 2016 2:38:05 GMT -5
Took Matt three days and he has a plan. The last CEO had 6 months plus and nothing.
Matt said all the right things, now it's time to start executing; starting with a TS partnership.
MNKD has returned to HOLD status rather than "let's all sit around and watch the boat sink and hope we can write it off on our taxes" strategy.
-- I think TS pain is still in the pipeline but it's no longer on the top of the list. MannKind is focusing on opportunities that they can bring to the market cheaply and quickly.
Pain would require some major cash (partner) and years of trials.
|
|
|
Post by parrerob on Jan 14, 2016 3:34:27 GMT -5
Guys I ve a PDF with the power point exctracted from JPM website. But I don't know how to attach here..... Suggestion ? Is it possible ?
Thanks
Just would be nice to have it in this thread, just for archiving reason too
EDIT: I found my self the answer.... No way to upload a file.... only pictures. Thanks anycase
|
|
|
Post by lakers on Jan 14, 2016 3:35:10 GMT -5
I found myself wondering about the TS pain medication that was previously in the pipeline and was missing from today's presentation. Is that possibly related to the TS partnership announcement that is allegedly days away? Yes. I was thinking the same thing. All this migraine patent activity flying around and then not one mention. Must be able to determine the partner if medication revealed? It sure would be nice to see a T/S deal announced in the next couple weeks. Maybe..... The final step is having Lawyers reviewing the language in the licensing agreement. This time it will be written such that upfront payment can be recognized immediately.
|
|
|
Post by parrerob on Jan 14, 2016 4:14:39 GMT -5
Please tell me you aren't serious? doubling your position only because Matt said positive things? Please be wiser than this ha. Our situation has not improved since yesterday. This is still a long shot. It just looks like MNKD employees are motivated and hungry to take it head on. Unless your position is relatively small, please don't double it yet. Wait until we at least get on stable ground. There are better places for your money until that time. thanks for your concern .. but I was already considering this before the conference .. so no I'm not jumping in just because of today..
The fact I could add my position with peanuts now is very attractive. But Personally I am satisfy with the quantity I have. Keeping my long position was and is still enough for me.
I made a lot of errors in the past. And I strongly hope to add another error to the list: not buying more today. But today I believe that not buying more is not an error, it is sanity ! We need to increase confidence from the market; so We strongly need NEW buyers (not, or not only, existing shareholders increasing... but New buyers, New confidence).
This is my opinion ....
|
|
|
Post by dt on Jan 14, 2016 4:52:42 GMT -5
Matt sounded more comfortable in the CEO seat - I think his natural tendency is to communicate, but previously as CFO AND being stuck in a highly confidential arrangement with Sanofi he was not able to speak directly or in the manner he wished. Yesterday seemed a more natural flow - he was telling investors about things they have been asking about, AND he was telling them without SPIN (IMHO).
For example, and I didnt see this highlighted in the previous summaries (my bad if I missed it), he discussed how the retention rate was lower than expected. Any previous call would have been "we continue to see encouraging signs that ...". In this call he just said it was lower, and then talked about how they were going to improve it.
I also feel there was a 180 degree change in how investors were viewed. Previously, no info, unclear info, ... (all that has been covered). Now he even said he wanted to have an ADDITIONAL call before the next earnings call to make sure investors are up to speed. Also, he also said that his goal is to increase investor confidence so that if selling shares is needed for funding it is at a higher PPS (well, I think I read into his comments a bit, but that is how I remember it)
We have such a long way to go to get the company valuation up to a more acceptable level, but I feel more positive than probably since FDA approval.
I can see: - there is not much more downside from here for shorts to gain from - Matt's communication style/approach is more difficult for a short to take advantage of than Hakan's - a path forward is being communicated - we arent stuck under Sanofi (and their 20 drug rollout clusterf*ck) - there is such a high level of accumulated tax losses that somebody should be able to benefit from that should form a floor to the share value
I believe the stock was at 1.50 PPS the day of the Sanofi letter.... I wonder what it will take to get back to and above that? Hopefully the TS licensing deal that Matt is keen to announce will get us back and above that threshold!
Good luck!
dt
|
|